Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling.

Related Articles

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling.

Sci Rep. 2017 Mar 23;7(1):372

Authors: Lin CM, Chen HH, Lin CA, Wu HC, Sheu JJ, Chen HJ

Abstract
The bioflavonoid apigenin has been shown to possess cancer-preventive and anti-cancer activities. In a drug screening, we found that apigenin can inhibit Wnt/β-catenin signaling, a pathway that participates in pivotal biological functions, which dis-regulation results in various human diseases including cancers. However, the underlying mechanism of apigenin in this pathway and its link to anti-cancer activities remain largely unknown. Here we showed that apigenin reduced the amount of total, cytoplasmic, and nuclear β-catenin, leading to the suppression in the β-catenin/TCF-mediated transcriptional activity, the expression of Wnt target genes, and cell proliferation of Wnt-stimulated P19 cells and Wnt-driven colorectal cancer cells. Western blotting and immunofluorescent staining analyses further revealed that apigenin could induce autophagy-mediated down-regulation of β-catenin in treated cells. Treatment with autophagy inhibitors wortmannin and chloroquine compromised this effect, substantiating the involvement of autophagy-lysosomal system on the degradation of β-catenin during Wnt signaling through inhibition of the AKT/mTOR signaling pathway. Our data not only pointed out a route for the inhibition of canonical Wnt signaling through the induction of autophagy-lysosomal degradation of key player β-catenin, but also suggested that apigenin or other treatments which can initiate this degradation event are potentially used for the therapy of Wnt-related diseases including cancers.

PMID: 28337019 [PubMed - in process]

from Head and Neck on PubMed via xlomafota13 on Inoreader http://ift.tt/2njo1na


http://ift.tt/2nBDscm